BOAN BIOTECH's stock price plummeted 5.15% during intraday trading on Tuesday, following the release of its annual financial results.

The sharp decline came after the company reported its full-year results for the period ending December 31, 2025. While revenue increased by 8.06% year-on-year to approximately RMB 785 million, profit attributable to owners narrowed dramatically by 90.24% to RMB 7.144 million. The significant profit contraction, despite revenue growth, likely triggered the negative investor sentiment and selling pressure.